Our current study showed that TS is highly expressed in NSCLC and that polymorphisms of TS 3’-UTR 1494del 6 bp are associated with lung adenocarcinoma patients’ sensitivity to pemetrexed treatment. Here, TYMS is linked to lung adenocarcinoma.